obp-301
Showing 1 - 2 of 2
Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease Trial in New York (OBP-301,
Terminated
- Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease
- OBP-301
- Pembrolizumab
-
New York, New YorkWeill Cornell Medicine
Jul 6, 2022
Melanoma Stage III, Melanoma Stage Iv Trial in Morristown (OBP-301)
Unknown status
- Melanoma Stage III
- Melanoma Stage Iv
- OBP-301
-
Morristown, New JerseyResearch Site
Apr 11, 2019